Phaxiam Therapeutics

概述

国家	France
成立时间	2004
总部	LYON, Rhône-Alpes
电话号码	+33 4 78 74 44 38
网站	http://www.erytech.com
LinkedIn	http://www.linkedin.com/company/phaxiam
Twitter	https://twitter.com/ERYTECH_PHARMA
Facebook
员工数	85
行业	biotechnology,
简介	PHAXIAM is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, which are responsible for many serious infections. The company is building on an innovative approach based on the use of phages, natural bacterial-killing viruses. PHAXIAM is developing a portfolio of phages targeting 3 of the most resistant and dangerous bacteria, which together account for more than two-thirds of resistant hospital-acquired infections: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. PHAXIAM is listed on the Nasdaq Capital Market in the United States (ticker: PHXM) and on the Euronext regulated market in Paris (ISIN code: FR0011471135, ticker: PHXM). PHAXIAM is part of the CAC Healthcare, CAC Pharma & Bio, CAC Mid & Small, CAC All Tradable, EnterNext PEA-PME 150 and Next Biotech indexes.

查看更多信息

技术

Google Tag Manager

Tag Management

Mobile Friendly

Other

New Relic

Web Performance Monitoring

Nginx

Load Balancers

Outlook

Email Providers

WordPress.org

CMS

查看所有技术

常见问题

Phaxiam Therapeutics 在哪里?

Phaxiam Therapeutics 的总部位于 LYON, Rhône-Alpes

Phaxiam Therapeutics 的电话号码是多少?

Phaxiam Therapeutics 的电话号码是 +33 4 78 74 44 38

Phaxiam Therapeutics 的官方网站是什么?

Phaxiam Therapeutics 的公司官方网站是 http://www.erytech.com

Phaxiam Therapeutics 是做什么的?

Phaxiam Therapeutics 的业务有哪些?

red blood cells,cell therapy,cancer metabolism,oncology,solid tumors,rare diseases,pancreatic cancer,acute lymphoblastic leukemia,clinicalstage,biotechnology,tnbc